Allogeneic CAR T cells CT0594CP
Term · Oncology and biomedicine · MLC-T-ONC-009838
A preparation of allogeneic T lymphocytes that have been genetically modified to express chimeric antigen receptors (CARs) specific for as of yet undisclosed tumor-associated antigens (TAAs), with potential immunostimulating and antineoplastic activities. Upon administration, allogeneic CAR T cells CT0594CP specifically targets and binds to tumor cells that express the undisclosed TAAs, resulting in tumor cell lysis.
| Identifier | MLC-T-ONC-009838 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | allogeneic CAR-T cells CT0594CP |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009838",
"term": "Allogeneic CAR T cells CT0594CP",
"field": "Oncology and biomedicine",
"definition": "A preparation of allogeneic T lymphocytes that have been genetically modified to express chimeric antigen receptors (CARs) specific for as of yet undisclosed tumor-associated antigens (TAAs), with potential immunostimulating and antineoplastic activities. Upon administration, allogeneic CAR T cells CT0594CP specifically targets and binds to tumor cells that express the undisclosed TAAs, resulting in tumor cell lysis.",
"synonyms": [
"allogeneic CAR-T cells CT0594CP"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/allogeneic-car-t-cells-ct0594cp/"
}
Record 724 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.